AzTrials
AzTrials

Frail ElderlyMEFAPNCT03568084

Effectiveness of an Intervention in Multicomponent Exercise in Patients Over 70 Years in Primary Care

A study testing MEFAP in people with Frail Elderly and Physical Activity, run by Gerencia de Atención Primaria, Madrid at 1 site in Spain.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Objective: To evaluate the effect of a multicomponent physical activity program, compared with the usual medical practice, to reverse prefrailty by Fried in people over 70 years, one year after the end of the intervention. Read more about this study

Who is it for?
Ages 70 to 100 years
Conditions the study is for
Frail Elderly, Physical Activity
What is being tested?
MEFAP
Could I receive a placebo?
No, everyone receives an active treatment
How many people
206 participants
Where
1 siteSpain
Study dates
1 Jul 2018to 10 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 to 100 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Individuals aged >70 years with a Barthel test ≥90 and pre-frailty (1-2 Fried phenotype frailty criteria).
  • For Health Care Centers: Centers who deliver patient to Physiotherapy Units who participate in this Project. Centers where at least two General Practitioners accept to participate in the Project.

Who cannot join

  • Moderate to severe dependency (impairment) for daily living activities (Barthel test <90)
  • Enable to achieve Health Care Center for any reason.
  • Moderate to severe cognitive impairment (MEC 35 Lobo≤21)
  • Severe illness that contraindicates to practice exercise by medical criteria: recent hearth attack (6 months), not controlled arrhythmia, severe hearth valvular disease, not controlled arterial hypertension (systolic blood pressure>180/diastolic blood pressure>100), severe heart failure, severe respiratory failure, diabetes mellitus with frequent acute hypoglycemia, any other circumstance that makes the individual unable to do exercise under medical criteria.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Maria Victoria Castell

    Madrid, 28035

Other trials in Spain

About this study

Official title: Effectiveness of an Intervention in Multicomponent Exercise (MEFAP) in Patients Over 70 Years in Primary Care: Reversibility of Prefrailty

Objective: To evaluate the effect of a multicomponent physical activity program, compared with the usual medical practice, to reverse prefrailty by Fried in people over 70 years, one year after the end of the intervention.

Read the detailed description

Objective: To evaluate the effect of a multicomponent physical activity program, compared with the usual medical practice, to reverse prefrailty by Fried in people over 70 years, one year after the end of the intervention.

Location: primary care setting (Madrid Region).

Population: non-dependent and pre-frailty patients ≥ 70 years old, who attend the health centers included in the study.

Design: Randomized parallel group multicenter clinical trial. Randomization unit and Unit of analysis: Patient.

Intervention: multicomponent physical activity program (MEFAP) with 12 weekly sessions of an hour and a half which includes 1) briefing 2) exercises for improving aerobic resistance, muscle strength, proprioception -balance and flexibility and 3) delivery of exercise chart to do at home (two times per week).

Main measures: Main variable: pre-frailty according to Fried phenotype. Secondary variables: sociodemographic, clinical and function variables; adherence, user satisfaction, quality of life.

Analysis: It will be carried out an analysis by intention to treat comparing the retrogression from pre-frailty (1 or 2 Fried criteria) to robust (0 Fried criteria) at the end of the intervention, 6 months after the intervention and one year after the intervention. Cumulative incidence, Relative Risk and Number Needed to Treat with a 95% Confidence Interval. A Generalized Estimating Equation logit model will be adjusted to analyze the associated factors.

Being tested
MEFAP, control usual practice
Keywords
elderly, physical activity, exercise, frailty
Medical subject headings
Motor Activity, Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MEFAPOther

    multicomponent physical activity program (MEFAP) with 12 weekly sessions of an hour and a half which includes 1) briefing 2) exercises for improving aerobic resistance, muscle strength, proprioception-balance and flexibility and 3) delivery of exercise chart to do at home (two times per week).

  • control usual practiceOther

    Individuals allocated to this arm, will be look after as usual in their health Centers.

Study groups in NCT03568084
Study groupRoleWhat they receive
MEFAPExperimentalMEFAP (multicomponent physical activity program) for 12 weekly sessions of an hour and a half which includes 1) briefing 2) exercises for improving aerobic resistance, muscle strength, proprioception-balance and flexibility and 3) delivery of exercise chart to do at home (two times per week).
Receives: Other: MEFAP; Other: control usual practice
Control: usual practiceActive comparatorNo intervention. Individuals allocated to this arm, will be look after as usual in their health Centers.
Receives: Other: control usual practice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline frail elderly level at one year

    It will be carried out an analysis by intention to treat comparing the retrogression from pre-frailty (1 or 2 Fried criteria) to robust (0 Fried criteria)

    Measured: one year after the intervention.

Secondary outcomes (5)
  1. Change from baseline frail elderly level at at the end of the intervention (12 weeks)

    It will be carried out an analysis by intention to treat comparing the retrogression from pre-frailty (1 or 2 Fried criteria) to robust (0 Fried criteria)

    Measured: at the end of the intervention (12 weeks)

  2. Change from baseline frail elderly level at at the at 6 month

    It will be carried out an analysis by intention to treat comparing the retrogression from pre-frailty (1 or 2 Fried criteria) to robust (0 Fried criteria)

    Measured: 6 month after the intervention

  3. Adherence to intervention

    degree of adherence to the program (number of sessions with assistance)

    Measured: at the end of the intervention (12 weeks)

  4. Euroqol utilities

    Euroqol descriptive system (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression)

    Measured: at the end of the intervention (12 weeks),

  5. Visual Analog Scale

    A Visual Analog Scale with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status)

    Measured: at the end of the intervention (12 weeks),

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2018
  2. Study start1 Jul 2018
  3. Primary completion1 Feb 2020
  4. Study completion10 Mar 2020

Why it stopped: SARS-CoV-2 Pandemic

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized parallel group multicenter clinical trial. Randomization unit and Unit of analysis: Patient.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
206 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03568084
Sponsor's protocol ID
PI17/01889
Acronym
MEFAP
Status last verified
Apr 2022
First submitted
24 May 2018
Last updated
18 Apr 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Castell MV, Gutierrez-Misis A, Sanchez-Martinez M, Prieto MA, Moreno B, Nunez S, Triano R, de Antonio MP, Mateo C, Cano MD, Garrido A, Julian R, Polentinos E, Rodriguez-Barrientos R, Otero Puime A; MEFAP Group. Effectiveness of an intervention in multicomponent exercise in primary care to improve frailty parameters in patients over 70 years of age (MEFAP-project), a randomised clinical trial: rationale and study design. BMC Geriatr. 2019 Jan 28;19(1):25. doi: 10.1186/s12877-018-1024-8.

    PubMed 30691405

Questions about this trial

What is this clinical trial studying?

A study testing MEFAP in people with Frail Elderly and Physical Activity, run by Gerencia de Atención Primaria, Madrid at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 18 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: SARS-CoV-2 Pandemic). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline frail elderly level at one year (time frame: one year after the intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03568084, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in